Today: January 22, 2019, 1:24 am
  
Business

Notification from Oasmia Pharmaceutical

PR-Inside.com: 2018-05-16 18:01:01

Oasmia Pharmaceutical AB (publ) hereby notify that the Company, Arwidsro Investment and MGC Capital have agreed to extend the payment of the loan, which was communicated January 2nd  until September 30th. The reason for the extension is to give the Company time to fulfil ongoing activities. All other terms apply unchanged for the loan.

About Oasmia Pharmaceutical AB
Oasmia Pharmaceutical AB develops, manufactures, markets and sells new generations of drugs in the field of human and veterinary oncology. The company’s product development aims to create and manufacture novel nanoparticle formulations and drug-delivery systems based on well-established cytostatics which, in comparison with current alternatives, show improved properties, reduced side-effects, and expanded applications. The company’s product development is based on its proprietary in-house research and company patents. Oasmia is listed on NASDAQ Capital Markets (OASM.US), Frankfurt Stock Exchange (OMAX.GR, ISIN SE0000722365) and NASDAQ Stockholm (OASM.ST).

Information is also available at www.oasmia.com www.nasdaqomxnordic.com www.boerse-frankfurt.de twitter.com/oasmia

This information is such that Oasmia Pharmaceutical AB (publ) is obliged to disclose under the EU Market Abuse Regulation (MAR). The information was submitted for publication, through the agency of the contact person set out above, at 18.00 CET on 16 May 2018.

Attachment




# 296 Words
Related Articles
More From The Author
SD-WAN Market Leader Aryaka Named Company of [..]
Light Reading recognizes global SD-WAN leader Aryaka for record-breaking growth, market-driven innovation, and unparalleled customer [..]
INGREDION INCORPORATED DECLARES QUARTERLY DIVIDEND OF [..]
WESTCHESTER, Ill., May 16, 2018 - Today, the Board of Directors of Ingredion Incorporated (NYSE: INGR) declared a quarterly dividend [..]
Bavarian Nordic to Host First Quarter 2018 [..]
COPENHAGEN, Denmark - May 16, 2018 - Bavarian Nordic A/S (OMX:  BAVA, OTC: BVNRY) will announce its 2018 first quarter [..]
Olvi:SHARE REPURCHASE 16.5.2018
Olvi PlcStock Exchange Release16.5.2018      SHARE REPURCHASE  16.5.2018     In the NASDAQ OMX Helsinki     Trade date 16.5.2018 Bourse [..]
Banks net position in the Riksbank
MAY 16, 2018 SEK MILLION   LENDINGBORROWING144   
 
More From Business
3,300+ Finance, Business Leaders Join Asian Financial [..]
HONG KONG, Jan 16, 2019 - (ACN Newswire) - More than 3,300 financial policymakers, financial elites and business leaders attended [..]
The Executive Talk: Chememan PCL (SET:CMAN)
BANGKOK, Jan 15, 2019 - (ACN Newswire) - Chememan PCL (SET:CMAN) Chief Executive Officer, Mr. Adisak Lowjun discusses the company's [..]
Sapphire's Subsidiary Awarded EPC Contract of RMB [..]
SINGAPORE, Jan 15, 2019 - (ACN Newswire) - SGX Mainboard-listed Sapphire Corporation Limited ("Sapphire", and together [..]
Hong Kong Investment Promotion chief visits London [..]
HONG KONG, Jan 14, 2019 - (ACN Newswire) - The Director-General of Investment Promotion of the Hong Kong Special Administrative [..]
Wildfire Design & Build Receives 2018 Best [..]
NAPA December 13, 2018 -- Wildfire Design & Build has been selected for the 2018 Best of Napa Award in [..]

Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.